vs
Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Caledonia Mining Corp Plc is the larger business by last-quarter revenue ($46.9M vs $39.6M, roughly 1.2× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 7.0%, a 28.9% gap on every dollar of revenue. On growth, Caledonia Mining Corp Plc posted the faster year-over-year revenue change (13.8% vs -10.9%). Over the past eight quarters, Caledonia Mining Corp Plc's revenue compounded faster (17.1% CAGR vs -15.0%).
Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CMCL vs SBC — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.9M | $39.6M |
| Net Profit | $3.3M | $14.2M |
| Gross Margin | 41.2% | 73.1% |
| Operating Margin | 18.6% | 32.5% |
| Net Margin | 7.0% | 35.9% |
| Revenue YoY | 13.8% | -10.9% |
| Net Profit YoY | -33.3% | 117.2% |
| EPS (diluted) | $0.13 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $39.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $43.4M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | — | $44.4M | ||
| Q3 24 | $46.9M | $53.1M | ||
| Q2 24 | $50.1M | $53.1M | ||
| Q1 24 | $38.5M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | — | $12.8M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $3.3M | $2.8M | ||
| Q2 24 | $10.2M | $18.5M | ||
| Q1 24 | $2.1M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | 41.2% | 81.5% | ||
| Q2 24 | 45.8% | 74.2% | ||
| Q1 24 | 35.9% | 72.1% |
| Q4 25 | — | 32.5% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 33.6% | ||
| Q1 25 | — | 51.1% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | 18.6% | 26.1% | ||
| Q2 24 | 32.2% | 51.4% | ||
| Q1 24 | 13.8% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 7.0% | 5.3% | ||
| Q2 24 | 20.3% | 34.8% | ||
| Q1 24 | 5.4% | 34.2% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $0.13 | $0.03 | ||
| Q2 24 | $0.42 | $0.20 | ||
| Q1 24 | $0.07 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.2M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $231.0M | $248.3M |
| Total Assets | $339.7M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | — | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | — | $125.0M | ||
| Q3 24 | $7.2M | $137.4M | ||
| Q2 24 | $15.4M | — | ||
| Q1 24 | $1.8M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $248.3M | ||
| Q3 25 | — | $248.0M | ||
| Q2 25 | — | $244.6M | ||
| Q1 25 | — | $226.4M | ||
| Q4 24 | — | $195.1M | ||
| Q3 24 | $231.0M | $205.0M | ||
| Q2 24 | $231.1M | $8.8M | ||
| Q1 24 | $220.3M | $9.0M |
| Q4 25 | — | $380.4M | ||
| Q3 25 | — | $321.4M | ||
| Q2 25 | — | $315.3M | ||
| Q1 25 | — | $284.6M | ||
| Q4 24 | — | $266.1M | ||
| Q3 24 | $339.7M | $296.5M | ||
| Q2 24 | $338.5M | $19.5M | ||
| Q1 24 | $321.8M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.6M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 1.40× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $52.0M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.3M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $-7.3M | ||
| Q3 24 | $4.6M | $5.0M | ||
| Q2 24 | $19.1M | $19.2M | ||
| Q1 24 | — | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 1.40× | 1.77× | ||
| Q2 24 | 1.87× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMCL
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
